Reaction
Cardiorenal Syndrome reporting signals
As of the last recalculation, Cardiorenal Syndrome appears in 563 FAERS reports alongside 18 co-occurring drug terms. The strongest observed disproportionality signal is AXICABTAGENE CILOLEUCEL (PRR 148.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Axicabtagene Ciloleucel | 37 | 148.3 | 148.8 |
| Isosorbide Mononitrate | 23 | 42.7 | 42.8 |
| Metolazone | 12 | 40.3 | 40.4 |
| Eplerenone | 13 | 38.4 | 38.4 |
| Tafamidis | 11 | 35.2 | 35.2 |
| Bumetanide | 18 | 26.0 | 26.0 |
| Mesna Injection | 5 | 22.6 | 22.6 |
| Mesna | 5 | 22.1 | 22.2 |
| Epoprostenol | 7 | 20.0 | 20.0 |
| Riociguat | 16 | 18.6 | 18.7 |
| Tolvaptan | 7 | 18.0 | 18.0 |
| Selexipag | 12 | 17.5 | 17.5 |
| Selinexor | 4 | 17.2 | 17.2 |
| Macitentan | 28 | 15.7 | 15.7 |
| Dapagliflozin | 13 | 15.6 | 15.6 |
| Sacubitril And Valsartan | 43 | 14.7 | 14.8 |
| Brentuximab Vedotin | 4 | 14.5 | 14.5 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 4 | 4.8 | 4.8 |